If mega-rich people could buy places on clinical trials, would this help drive forward the development of new treatments that could benefit everyone? Alexander Masters thinks it might just work.
Written and read by Alexander Masters
Produced by Barry J Gibb
Edited by Geoff Marsh
This article won the Best Investigative Journalism award at the 2015 Association of British Science Writers Awards.
Read the full text original published on Mosaic.
For more stories visit mosaicscience.com
If you liked this story, we recommend Why a ‘miracle’ drug exists but you can’t have it yet, by Andy Extance.
Subscribe to the Mosaic podcast on iTunes or wherever you get your podcasts. Please leave us a rating and review!